A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non‐small‐cell lung cancer who have progressed after anti‐PD‐1/L1 therapy

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yuguang Zhao, Xiao Chen, Jun Yao, Jianlin Long, Yong Mao, Di Wu, Aimin Zang, Jun Zhao, Ziling Liu, Rui Meng, Ye Chen, Yang Luo, Qun Guo, Li Li, Jiuwei Cui
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Cancer Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet